Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,250,001
-$20,466,705 QoQ
Shares Held
2,307
-93.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#428
of 870 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Jun 30, 2026CallValue
$325,098
CallShares
600
PutValue
$2,654,967
PutShares
4,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $126,095,704 across 18 Drug Manufacturers - Specialty & Generic names. UTHR ranks #12 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
277,821 | $30,821,461 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
309,682 | $19,804,163 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
702,858 | $17,227,049 | |
| 4 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
684,974 | $12,302,133 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
511,336 | $8,196,716 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
218,958 | $7,591,273 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
434,132 | $7,514,824 | |
| 8 | ALKS |
Alkermes plc.
|
142,366 | $7,459,978 |
All Filings in UTHR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,250,001 | 2,307 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $2,654,967 | 4,900 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $325,098 | 600 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $21,716,706 | 36,623 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,253,841 | 55,934 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,624,325 | 32,500 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $61,581,110 | 146,898 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,886,103 | 152,727 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,884,229 | 15,844 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $14,613,889 | 66,460 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,191,118 | 80,538 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,955,827 | 40,570 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,338,385 | 59,557 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $12,441,190 | 44,738 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $33,454,108 | 159,777 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $24,648,886 | 104,604 | Shares | Sole | 2022-08-15 | |
| 2022-06-30 | $6,126,640 | 26,000 | Call | Sole | 2022-08-15 | |
| 2021-09-30 | $1,830,664 | 9,918 | Shares | Sole | 2021-12-01 | |
| 2021-03-31 | $2,051,232 | 12,263 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,316,322 | 8,672 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||